Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Investment Trusts

International Biotechnology Trust

IBT:LSE

International Biotechnology Trust

Actions
  • Price (GBX)672.00
  • Today's Change4.00 / 0.60%
  • Shares traded37.69k
  • 1 Year change+5.99%
  • Beta0.1890
Data delayed at least 15 minutes, as of Sep 27 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PriceInternational Biotechnology Trust (Ordinary Share)+10.50%
NAVInternational Biotechnology Trust (Ordinary Share)+20.09%
Morningstar's BenchmarkNasdaq Biotechnology Index--

Events & Activity

  • IBT:LSE price moved over -1.03% to 673.00
  • IBT:LSE price rises above 15-day moving average to 681.01 at 05:09 BST
  • IBT:LSE price rises above 15-day moving average to 682.00 at 08:15 BST

Key statistics

On Friday, International Biotechnology Trust (IBT:LSE) closed at 672.00, -6.67% below its 52-week high of 720.00, set on Jul 26, 2024.
52-week range
Today
548.00Oct 27 2023720.00Jul 26 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding36.74m
Market cap244.95m GBP
Total assets290.55m GBP
Total expense ratio1.44%
High680.00
Low666.00
Previous close672.00
Average volume44.87k
YTD Change+4.67%
Beta0.1890
Diluted NAV (est)740.54
Diluted NAV (last pub)726.06
Premium/Discount-9.26%
Net Gearing+5.60%
Annual div (ADY)28.40
GBX
Annual div yield (ADY)4.23%
Div ex-dateJul 25 2024
Div pay-dateAug 23 2024
Data delayed at least 15 minutes, as of Sep 27 2024 16:35 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.